Sino Biopharmaceutical Li... (SBMFF)
OTC: SBMFF
· Real-Time Price · USD
0.99
0.00 (0.10%)
At close: Aug 13, 2025, 12:40 PM
0.99
0.00%
After-hours: Aug 14, 2025, 08:00 PM EDT
Sino Biopharmaceutical Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 241.34M | 241.34M | 1.51B | 1.51B | n/a | 629.39M | 629.39M | 311.27M | 311.27M | 960.52M | 960.52M | 3.06B | 3.06B | 6.57B | 1.91B |
Depreciation & Amortization | n/a | n/a | 255.12M | 255.12M | n/a | 326.6M | 326.6M | 279.43M | 279.43M | 204.34M | 204.34M | 254.79M | 254.79M | n/a | n/a |
Stock-Based Compensation | 26.86M | 26.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.86M | 14.86M | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 299.17M | 299.17M | n/a | n/a | 609.07M | 609.07M | n/a | n/a |
Other Non-Cash Items | -268.2M | -268.2M | -224.45M | -224.45M | n/a | 379.56M | 379.56M | 463.79M | 567.41M | 794.75M | 794.75M | -1.73B | -1.73B | -6.57B | -1.91B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 103.62M | -107.21M | n/a | n/a | -73.77M | -73.77M | n/a | n/a |
Operating Cash Flow | n/a | n/a | 1.54B | 1.54B | n/a | 1.34B | 1.34B | 1.16B | 1.16B | 1.97B | 1.97B | 1.52B | 1.52B | n/a | n/a |
Capital Expenditures | n/a | n/a | -203.75M | -203.75M | n/a | -376.95M | -376.95M | -308.18M | -308.18M | -313.49M | -313.49M | -564.26M | -564.26M | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 229K | 229K | n/a | n/a | n/a | n/a | -20.8M | -20.8M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -816.71M | -816.71M | n/a | -1.66B | -1.66B | 1.27B | 1.27B | -2.68B | -2.68B | 1.36B | 1.36B | n/a | n/a |
Investing Cash Flow | n/a | n/a | -1.02B | -1.02B | n/a | -2.04B | -2.04B | 959.42M | 959.42M | -2.99B | -2.99B | 770M | 770M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -180.78M | -180.78M | n/a | -117.85M | -117.85M | -29.15M | -29.15M | -404.66M | -404.66M | -166.47M | -166.47M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -633.81M | n/a | n/a | n/a | -469.24M | -469.24M | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -1.87B | -1.87B | n/a | -1.9B | -1.9B | -199.97M | -833.78M | -325.61M | -325.61M | -596.08M | -596.08M | n/a | n/a |
Financial Cash Flow | n/a | n/a | -2.05B | -2.05B | n/a | -2.02B | -2.02B | -862.93M | -862.93M | -730.26M | -730.26M | -1.23B | -1.23B | n/a | n/a |
Net Cash Flow | n/a | n/a | -1.52B | -1.52B | n/a | -2.68B | -2.68B | 1.29B | 1.29B | -1.77B | -1.77B | 785.61M | 785.61M | n/a | n/a |
Free Cash Flow | n/a | n/a | 1.34B | 1.34B | n/a | 958.61M | 958.61M | 849.93M | 849.93M | 1.66B | 1.66B | 951.11M | 951.11M | n/a | n/a |